BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 9166828)

  • 1. Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID-repopulating cell assay.
    Wang JC; Doedens M; Dick JE
    Blood; 1997 Jun; 89(11):3919-24. PubMed ID: 9166828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential maintenance of primitive human SCID-repopulating cells, clonogenic progenitors, and long-term culture-initiating cells after incubation on human bone marrow stromal cells.
    Gan OI; Murdoch B; Larochelle A; Dick JE
    Blood; 1997 Jul; 90(2):641-50. PubMed ID: 9226164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid/scid mice.
    Conneally E; Cashman J; Petzer A; Eaves C
    Proc Natl Acad Sci U S A; 1997 Sep; 94(18):9836-41. PubMed ID: 9275212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo evidence for the long-term multilineage (myeloid, B, NK, and T) reconstitution capacity of ex vivo expanded human CD34(+) cord blood cells.
    Kobari L; Pflumio F; Giarratana M; Li X; Titeux M; Izac B; Leteurtre F; Coulombel L; Douay L
    Exp Hematol; 2000 Dec; 28(12):1470-80. PubMed ID: 11146169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expansion of human cord blood CD34(+)CD38(-) cells in ex vivo culture during retroviral transduction without a corresponding increase in SCID repopulating cell (SRC) frequency: dissociation of SRC phenotype and function.
    Dorrell C; Gan OI; Pereira DS; Hawley RG; Dick JE
    Blood; 2000 Jan; 95(1):102-10. PubMed ID: 10607692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional analysis of human hematopoietic repopulating cells mobilized with granulocyte colony-stimulating factor alone versus granulocyte colony-stimulating factor in combination with stem cell factor.
    Hess DA; Levac KD; Karanu FN; Rosu-Myles M; White MJ; Gallacher L; Murdoch B; Keeney M; Ottowski P; Foley R; Chin-Yee I; Bhatia M
    Blood; 2002 Aug; 100(3):869-78. PubMed ID: 12130497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex vivo culture with human brain endothelial cells increases the SCID-repopulating capacity of adult human bone marrow.
    Chute JP; Saini AA; Chute DJ; Wells MR; Clark WB; Harlan DM; Park J; Stull MK; Civin C; Davis TA
    Blood; 2002 Dec; 100(13):4433-9. PubMed ID: 12393435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematopoietic repopulating ability of cord blood CD34(+) cells in NOD/Shi-scid mice.
    Ueda T; Yoshino H; Kobayashi K; Kawahata M; Ebihara Y; Ito M; Asano S; Nakahata T; Tsuji K
    Stem Cells; 2000; 18(3):204-13. PubMed ID: 10840074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice.
    Bhatia M; Wang JC; Kapp U; Bonnet D; Dick JE
    Proc Natl Acad Sci U S A; 1997 May; 94(10):5320-5. PubMed ID: 9144235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transduction of human CD34+ CD38- bone marrow and cord blood-derived SCID-repopulating cells with third-generation lentiviral vectors.
    Guenechea G; Gan OI; Inamitsu T; Dorrell C; Pereira DS; Kelly M; Naldini L; Dick JE
    Mol Ther; 2000 Jun; 1(6):566-73. PubMed ID: 10933981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. beta2 microglobulin-deficient (B2m(null)) NOD/SCID mice are excellent recipients for studying human stem cell function.
    Kollet O; Peled A; Byk T; Ben-Hur H; Greiner D; Shultz L; Lapidot T
    Blood; 2000 May; 95(10):3102-5. PubMed ID: 10807775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cobblestone area-forming cells, long-term culture-initiating cells and NOD/SCID repopulating cells in human neonatal blood: a comparison with umbilical cord blood.
    Zhang XB; Li K; Fok TF; Li CK; James AE; Lam AC; Lee SM; Yuen PM
    Bone Marrow Transplant; 2002 Nov; 30(9):557-64. PubMed ID: 12407429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative assessment of retroviral transfer of the human multidrug resistance 1 gene to human mobilized peripheral blood progenitor cells engrafted in nonobese diabetic/severe combined immunodeficient mice.
    Schiedlmeier B; Kühlcke K; Eckert HG; Baum C; Zeller WJ; Fruehauf S
    Blood; 2000 Feb; 95(4):1237-48. PubMed ID: 10666196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seeding efficiency of primitive human hematopoietic cells in nonobese diabetic/severe combined immune deficiency mice: implications for stem cell frequency assessment.
    van Hennik PB; de Koning AE; Ploemacher RE
    Blood; 1999 Nov; 94(9):3055-61. PubMed ID: 10556189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed engraftment of nonobese diabetic/severe combined immunodeficient mice transplanted with ex vivo-expanded human CD34(+) cord blood cells.
    Guenechea G; Segovia JC; Albella B; Lamana M; Ramírez M; Regidor C; Fernández MN; Bueren JA
    Blood; 1999 Feb; 93(3):1097-105. PubMed ID: 9920860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of non-obese diabetic (NOD)/Severe-combined immunodeficient mice (SCID) with flt3 ligand and interleukin-7 impairs the B-lineage commitment of repopulating cells after transplantation of human hematopoietic cells.
    Kapp U; Bhatia M; Bonnet D; Murdoch B; Dick JE
    Blood; 1998 Sep; 92(6):2024-31. PubMed ID: 9731060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A highly sensitive strategy for SCID-repopulating cell assay by direct injection of primitive human hematopoietic cells into NOD/SCID mice bone marrow.
    Yahata T; Ando K; Sato T; Miyatake H; Nakamura Y; Muguruma Y; Kato S; Hotta T
    Blood; 2003 Apr; 101(8):2905-13. PubMed ID: 12411299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional differences between transplantable human hematopoietic stem cells from fetal liver, cord blood, and adult marrow.
    Holyoake TL; Nicolini FE; Eaves CJ
    Exp Hematol; 1999 Sep; 27(9):1418-27. PubMed ID: 10480433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotype and function of human hematopoietic cells engrafting immune-deficient CB17-severe combined immunodeficiency mice and nonobese diabetic-severe combined immunodeficiency mice after transplantation of human cord blood mononuclear cells.
    Pflumio F; Izac B; Katz A; Shultz LD; Vainchenker W; Coulombel L
    Blood; 1996 Nov; 88(10):3731-40. PubMed ID: 8916937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased risk of lethal graft-versus-host disease-like syndrome after transplantation into NOD/SCID mice of human mobilized peripheral blood stem cells, as compared to bone marrow or cord blood.
    Gorin NC; Piantadosi S; Stull M; Bonte H; Wingard JR; Civin C
    J Hematother Stem Cell Res; 2002 Apr; 11(2):277-92. PubMed ID: 11983099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.